The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - Results from the randomized DAHANCA 5 study

Radiotherapy and Oncology

Volumn 98, Issue 1, 2011, Pages 28-33

  Hoff, Camilla Molich ^a   Hansen, Hanne Sand ^b   Overgaard, Marie ^a   Grau, Cai ^a   Johansen, Jørgen ^c   Bentzen, Jens ^d   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Haemoglobin; Head and neck squamous cell cancer; Hypoxia; Radiotherapy; Randomized trial; Transfusion

Indexed keywords

HEMOGLOBIN; NIMORAZOLE; PLACEBO;

ADULT; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; BLOOD TRANSFUSION; CARCINOMA; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; TREATMENT OUTCOME;

EID: 78651367214     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.09.024     Document Type: Article

References (43)

1. J. Overgaard, H.S. Hansen, K. Jorgensen, and H.M. Hjelm Primary radiotherapy of larynx and pharynx carcinoma - an analysis of some factors influencing local control and survival Int J Radiat Oncol Biol Phys 12 1986 515 521 (Pubitemid 16081611)
2. J. Overgaard Sensitization of hypoxic tumour cells - clinical experience Int J Radiat Biol 56 1989 801 811 (Pubitemid 20002032)
3. C. Grau, and J. Overgaard Significance of hemoglobin concentration for treatment outcome M. Molls, P. Vaupel, Blood perfusion and microenvironment of human tumors, implications for clinical radiooncology 1998 Springer Berlin 101 112
4. M. Nordsmark, and J. Overgaard Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer Acta Oncol 43 2004 396 403 (Pubitemid 38887861)
5. M.R. Horsman Measurement of tumor oxygenation Int J Radiat Oncol Biol Phys 42 1998 701 704
6. J. Overgaard Hypoxic radiosensitization: adored and ignored J Clin Oncol 25 2007 4066 4074 (Pubitemid 47492951)
7. M. Nordsmark, S.M. Bentzen, V. Rudat, D. Brizel, E. Lartigau, and P. Stadler Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24 (Pubitemid 41503384)
8. P. Stadler, A. Becker, H.J. Feldmann, G. Hansgen, J. Dunst, and F. Wurschmidt Influence of the hypoxic subvolume on the survival of patients with head and neck cancer Int J Radiat Oncol Biol Phys 44 1999 749 754 (Pubitemid 29284123)
9. M. Henke, R. Laszig, C. Rube, U. Schafer, K.D. Haase, and B. Schilcher Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260 (Pubitemid 37324251)
10. M. Machtay, T.F. Pajak, M. Suntharalingam, G. Shenouda, D. Hershock, and D.C. Stripp Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03) Int J Radiat Oncol Biol Phys 69 2007 1008 1017 (Pubitemid 47625834)
11. P.J. Hoskin, M. Robinson, N. Slevin, D. Morgan, K. Harrington, and C. Gaffney Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer J Clin Oncol 27 2009 5751 5756
12. L. Barbera, and G. Thomas Erythropoiesis stimulating agents, thrombosis and cancer Radiother Oncol 95 2010 269 276
13. J. Overgaard, C.M. Hoff, H.S. Hansen, L. Specht, M. Overgaard, and C. Grau Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial J Clin Oncol 27 2009 [abstr 6007]
14. J.C. Evans, and P. Bergsjo The influence of anemia on the results of radiotherapy in carcinoma of the cervix Radiology 84 1965 709 717
15. P. Vaupel, A. Mayer, and M. Hockel Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol 182 2006 63 71 (Pubitemid 43177190)
16. D.G. Hirst, and P.J. Wood The adaptive response of mouse tumours to anaemia and retransfusion Int J Radiat Biol Relat Stud Phys Chem Med 51 1987 597 609
17. R.P. Hill, R.S. Bush, and P. Yeung The effect of anaemia on the fraction of hypoxic cells in an experimental tumour Br J Radiol 44 1971 299 304
18. H.B. Hewitt, and E.R. Blake Effect of induced host anaemia on the viability and radiosensitivity of murine malignant cells in vivo Br J Cancer 25 1971 323 336
19. D.G. Hirst, and J.M. Brown The influence of hemoglobin level on radiobiological hypoxia in tumors Adv Exp Med Biol 200 1986 603 608
20. R. Sealy, P. Jacobs, L. Wood, W. Levin, L. Barry, and J. Boniaszczuk The treatment of tumors by the induction of anemia and irradiation in hyperbaric oxygen Cancer 64 1989 646 652 (Pubitemid 19185214)
21. E.A. Levine, and S. Vijayakumar Blood transfusion in patients receiving radical radiotherapy: a reappraisal Onkologie 16 1993 79 87 (Pubitemid 23221181)
22. W.R. Lee, B. Berkey, V. Marcial, K.K. Fu, J.S. Cooper, and B. Vikram Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27 Int J Radiat Oncol Biol Phys 42 1998 1069 1075 (Pubitemid 29004150)
23. S. Dische, P.J. Anderson, R. Sealy, and E.R. Watson Carcinoma of the cervix - anaemia, radiotherapy and hyperbaric oxygen Br J Radiol 56 1983 251 255 (Pubitemid 13119078)
24. J. Varlotto, and M.A. Stevenson Anemia, tumor hypoxemia, and the cancer patient Int J Radiat Oncol Biol Phys 63 2005 25 36 (Pubitemid 41583539)
25. A. Fortin, C.S. Wang, and E. Vigneault Effect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancer Int J Radiat Oncol Biol Phys 72 2008 255 260
26. R.S. Bush, R.D. Jenkin, W.E. Allt, F.A. Beale, H. Bean, and A.J. Dembo Definitive evidence for hypoxic cells influencing cure in cancer therapy Br J Cancer Suppl 3 1978 302 306
27. A.W. Fyles, M. Milosevic, M. Pintilie, A. Syed, and R.P. Hill Anemia, hypoxia and transfusion in patients with cervix cancer: a review Radiother Oncol 57 2000 13 19
28. M. Grogan, G.M. Thomas, I. Melamed, F.L. Wong, R.G. Pearcey, and P.K. Joseph The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix Cancer 86 1999 1528 1536 (Pubitemid 29489787)
29. J. Overgaard, H.S. Hansen, M. Overgaard, L. Bastholt, A. Berthelsen, and L. Specht A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85 Radiother Oncol 46 1998 135 146 (Pubitemid 28109172)
30. J. Overgaard, J.G. Eriksen, M. Nordsmark, J. Alsner, and M.R. Horsman Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial Lancet Oncol 6 2005 757 764 (Pubitemid 41430716)
31. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30 35
32. D. Pedersen, H. Sogaard, J. Overgaard, and S.M. Bentzen Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone Acta Oncol 34 1995 787 795
33. K.S. Kapp, J. Poschauko, E. Geyer, A. Berghold, A.C. Oechs, and E. Petru Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy Int J Radiat Oncol Biol Phys 54 2002 58 66
34. D.G. Hirst Anemia: a problem or an opportunity in radiotherapy? Int J Radiat Oncol Biol Phys 12 1986 2009 2017
35. A.R. Jensen, H.M. Nellemann, and J. Overgaard Tumor progression in waiting time for radiotherapy in head and neck cancer Radiother Oncol 84 2007 5 10 (Pubitemid 47039177)
36. A.C. Begg, K. Haustermans, A.A. Hart, S. Dische, M. Saunders, and B. Zackrisson The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis Radiother Oncol 50 1999 13 23 (Pubitemid 29136733)
37. D.G. Hirst What is the importance of anaemia in radiotherapy? The value of animal studies Radiother Oncol 20 1991 29 33
38. A.C. Koong, and D.G. Hirst The influence of chronic anaemia on the radiosensitivity of two mouse tumours Br J Cancer 63 1991 499 502
39. J. Overgaard, H.S. Hansen, A.P. Andersen, M. Hjelm-Hansen, K. Jorgensen, and E. Sandberg Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study Int J Radiat Oncol Biol Phys 16 1989 1065 1068 (Pubitemid 19154303)
40. J. Overgaard The influence of haemoglobin concentration on the response to radiotherapi Scand J Clin Lab Invest 48 1988 49 53
41. J. Overgaard, J.E. Nielsen, and C. Grau Effect of carboxyhemoglobin on tumor oxygen unloading capacity in patients with squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 22 1992 407 410
42. J. Hald, J. Overgaard, and C. Grau Evaluation of objective measures of smoking status-a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy Acta Oncol 42 2003 154 159 (Pubitemid 36570780)
43. C. Grau, A.A. Khalil, M. Nordsmark, M.R. Horsman, and J. Overgaard The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo Br J Cancer 69 1994 50 57 (Pubitemid 24021822)